Organon (1OGN) Financial Statements
Organon Financial Overview
Organon's market cap is currently $3.24B. The company's EPS TTM is $0.79; its P/E ratio is 17.52; and it has a dividend yield of 0.56%. Organon has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 6.22B | $ 6.40B | $ 6.26B | $ 6.17B | $ 6.30B |
| Gross Profit | $ 3.36B | $ 3.71B | $ 3.75B | $ 3.88B | $ 3.92B |
| Operating Income | $ 1.28B | $ 1.49B | $ 1.33B | $ 1.71B | $ 1.92B |
| EBITDA | $ 1.29B | $ 1.60B | $ 1.44B | $ 1.76B | $ 1.98B |
| Net Income | $ 187.00M | $ 864.00M | $ 1.02B | $ 917.00M | $ 1.35B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 574.00M | $ 675.00M | $ 693.00M | $ 706.00M | $ 737.00M |
| Total Assets | $ 12.87B | $ 13.10B | $ 12.06B | $ 10.96B | $ 10.68B |
| Total Debt | $ 8.80B | $ 9.04B | $ 8.93B | $ 9.11B | $ 9.36B |
| Net Debt | $ 8.23B | $ 8.36B | $ 8.24B | $ 8.41B | $ 8.63B |
| Total Liabilities | $ 12.12B | $ 12.63B | $ 12.13B | $ 11.85B | $ 12.19B |
| Stockholders' Equity | $ 752.00M | $ 472.00M | $ -70.00M | $ -892.00M | $ -1.51B |
| Cash Flow | |||||
| Free Cash Flow | $ 538.00M | $ 588.00M | $ 538.00M | $ 431.00M | $ 1.97B |
| Operating Cash Flow | $ 700.00M | $ 939.00M | $ 799.00M | $ 858.00M | $ 2.46B |
| Investing Cash Flow | $ -390.00M | $ -513.00M | $ -260.00M | $ -420.00M | $ -481.00M |
| Financing Cash Flow | $ -561.00M | $ -368.00M | $ -569.00M | $ -433.00M | $ -1.33B |
Currency in USD